Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery

Completed · Not applicable

Conditions studied: Anemia

In brief

The primary purpose of this study is to determine the best blood level to begin transfusing red blood cells in individuals undergoing cardiac surgery. The secondary aim is to determine the impact of red cell transfusion on health-related quality of life following surgery.

Key facts

Study ID

NCT00651573

Run by

The Cleveland Clinic

People needed

722

Starts

2007-03-01

Expected to finish

2019-01-03

Last updated by the study team

2019-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All primary and reoperative adult cardiac surgical patients undergoing cardiopulmonary bypass for coronary artery bypass grafting, coronary artery bypass grafting with a valve procedure, isolated valve procedures and ascending aortic repair for aneurysm or dissection procedures.

You may not qualify if…

• Age less than 18 years
• Congenital procedures
• Emergencies
• descending thoracic aortic aneurysm repairs
• Left or right ventricular assist devices
• Left ventricular aneurysm resections
• Heart or lung transplantation
• Those unable to receive blood for religious reasons

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States
• S.A.L. Hospital and Medical Institute — Ahmedabad, Thaltej,, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.